During a hearing, representatives for the Newsom administration said they could not provide a timeline for when state-produced insulin would be for sale.

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Gov. Gavin Newsom promised a “2024 delivery” for a state-branded, low-cost insulin. It still is not here, and the American Diabetes Association says the lag is hurting diabetics who need a low ...

Modular Medical (Nasdaq:MODD) announced that it entered into definitive subscription agreements worth proceeds of approximately $12 million.

A Newsom 2028 presidential run may be in the works based on the California governor's recent moves, but his failures could haunt a future White House bid.

the state’s project for creating and distributing low-cost, common medicines. In 2023, Newsom announced that CalRx would make its own biosimilar insulin available the following year. But it’s ...

In California, the state had used $100 million from its own budget towards manufacturing its own low-cost insulin. As a result, clear action was being taken to address the cost of insulin.

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here. Stay up-to-date with free briefings on topics that matter to ...

Gov. Gavin Newsom promised a “2024 delivery” for the insulin. It still is not here, and the American Diabetes Association says the lag is hurting diabetics who need a low-cost option for the ...